Penicillamine
Penicillamine is a prescription medication used as an antirheumatic agent to treat conditions like rheumatoid arthritis. It comes as 250 mg oral tablets, manufactured by Lupin Pharmaceuticals, Inc. (NDC: 70748-153). This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Penicillamine is a prescription medication used as an antirheumatic agent to treat conditions like rheumatoid arthritis. It comes as 250 mg oral tablets, manufactured by Lupin Pharmaceuticals, Inc. (NDC: 70748-153). This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Penicillamine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Penicillamine — ANDA 214363 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214363"
}
]
|
| identifier | ANDA214363 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"fda",
"health-care",
"medications",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Penicillamine |
